Who owns the CURTANA PHARMACEUTICALS trademark?

The CURTANA PHARMACEUTICALS trademark is owned by Curtana Pharmaceuticals.

What class is the CURTANA PHARMACEUTICALS trademark registered in?

The CURTANA PHARMACEUTICALS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for CURTANA PHARMACEUTICALS?

The USPTO serial number for CURTANA PHARMACEUTICALS is 99144507.

What is the registration number for CURTANA PHARMACEUTICALS?

CURTANA PHARMACEUTICALS is registered under USPTO registration number 8183648.

CUR

USPTO Trademark Record

REGISTERED

CURTANA PHARMACEUTICALS

SN 99144507·Reg 8183648·Filed Apr 18, 2025

Owner Curtana Pharmaceuticals

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CURTANA PHARMACEUTICALS (Serial No. 99144507), Registration No. 8183648, is a registered US trademark filed on Apr 18, 2025 by Curtana Pharmaceuticals. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: March 24, 2032

Mark Intelligence

CURTANA PHARMACEUTICALS (Reg. #8183648) is a registered US trademark that has been protecting its owner, Curtana Pharmaceuticals, since 2025. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 18, 2025

SERIAL

99144507

REG#

8183648

REGISTERED

Mar 24, 2026

Owner

Applicant

Curtana Pharmaceuticals

Entity

Corporation

State

Address

10900 Stonelake Blvd., Building 2, Suite 100, Austin, TX, 78759

Country

Attorney

Law firm

Curtana Pharmaceuticals

Address

10900 Stonelake Blvd., Building 2, Suite 100, Austin, TX 78759, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateApr 18, 2025

Serial Number99144507

Registration No.8183648

Registration DateMar 24, 2026

Status DateMar 24, 2026

Published for OppositionFeb 03, 2026

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: May 05, 2013

First use in commerce: Apr 30, 2015

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

21 events

REGISTERED-PRINCIPAL REGISTER

Mar 24, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Mar 24, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Feb 03, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 03, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 28, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 12, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS PETITION TO REVIVE RECEIVED

Jan 10, 2026

TEAS PETITION TO REVIVE RECEIVED

PETITION TO REVIVE-GRANTED

Jan 10, 2026

PETITION TO REVIVE-GRANTED

NOTICE OF REVIVAL - E-MAILED

Jan 10, 2026

NOTICE OF REVIVAL - E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 10, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 10, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 10, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Jan 08, 2026

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Jan 08, 2026

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

NON-FINAL ACTION WRITTEN

Sep 24, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 24, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 24, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Sep 12, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 11, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 18, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Apr 18, 2025

APPLICATION FILING RECEIPT MAILED

CURTANA PHARMACEUTICALS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks in Class 042 — Scientific, technology & SaaS services

Resources

Company